SCHEMBL4435120

SCHEMBL4435120

NC(=O)c1cnccc1Nc1ccc2cn[nH]c2c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 10/20 0.55
JAK3 P52333 4/20 0.53
MAP4K4 O95819 4/20 0.53
CLK2 P49760 4/20 0.53
DYRK1A Q13627 4/20 0.53
CLK4 Q9HAZ1 4/20 0.53
DAPK3 O43293 3/20 0.53
PRKD3 O94806 3/20 0.53
PAK4 O96013 3/20 0.53
PIM1 P11309 3/20 0.53
PRKACA P17612 3/20 0.53
CDK2 P24941 3/20 0.53
FLT3 P36888 3/20 0.53
CSNK1A1 P48729 3/20 0.53
CDK9 P50750 3/20 0.53
CDK5 Q00535 3/20 0.53
MAP4K2 Q12851 3/20 0.53
STK3 Q13188 3/20 0.53
PKN2 Q16513 3/20 0.53
HIPK2 Q9H2X6 3/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27627560 0.85 SYK (0.64) SYKJAK3MAP4K4CLK2DYRK1A
SCHEMBL2717397 0.81 MAPK9 (0.51) ROCK2MAPK9ROCK1KDM4EHTT
SCHEMBL2717012 0.81 MAPK9 (0.51) ROCK2MAPK9ROCK1TDP1
SCHEMBL8543979 0.78 EIF2AK2 (0.50) SYKJAK3MAP4K4CLK2DYRK1A
SCHEMBL4435114 0.77 KDR (0.65) SYKJAK3MAP4K4CLK2DYRK1A
Hydrochloric Acid SCHEMBL6246305 0.76 KDR (0.64) SYKJAK3MAP4K4CLK2DYRK1A
SCHEMBL5413116 0.76 JAK3 (0.62) SYKJAK3MAP4K4CLK2DYRK1A
SCHEMBL2715880 0.76 MAPK9 (0.49) SYKIRAK4MAPK8MAPK9CDK8
SCHEMBL4560491 0.75 SYK (0.59) SYKJAK3MAP4K4CLK2DYRK1A
SCHEMBL10242654 0.74 SYK (0.73) SYKJAK3MAP4K4CLK2DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4392348-B2 2009-12-24 JP claimed
JP-4338974-B2 2009-10-07 JP claimed
JP-2006502118-A 2006-01-19 JP claimed
EP-1562933-A2 SUBSTITUTED AMINE DERIVATIVES AND METHODS OF USE IN THE TREATMENT OF ANGIOGENESIS RELATED DISORDERS Amgen Inc. (US) 2005-08-17 EP claimed
EP-1467721-A2 SUBSTITUTED AMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF ANGIOGENESIS Amgen Inc. (US) 2004-10-20 EP claimed
JP-2004527499-A 2004-09-09 JP claimed
WO-2004007481-A2 SUBSTITUTED AMINE DERIVATIVES AND METHODS OF USE IN THE TREATMENT OF ANGIOGENESIS RELATES DISORDERS AMGEN INC. (US) 2004-01-22 WO claimed
WO-2002068406-A2 SUBSTITUTED AMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF ANGIOGENESIS AMGEN INC. (US) 2002-09-06 WO claimed
EP-1585743-A1 2-(1H-INDAZOL-6-YLAMINO)- BENZAMIDE COMPOUNDS AS PROTEIN KINASES INHIBITORS USEFUL FOR THE TREATMENT OF OPHTHALMIC DISEASES PFIZER INC. (US) 2005-10-19 EP disclosed
WO-2004056806-A1 2-(1H-INDAZOL-6-YLAMINO)-BENZAMIDE COMPOUNDS AS PROTEIN KINASES INHIBITORS USEFUL FOR THE TREATMENT OF OPHTALMIC DISEASES PFIZER INC. (US) 2004-07-08 WO disclosed